Originally Posted by
SparkyTheClown
Blobbies, a couple of points.
1. I suspect the growth required to have Hershey running at maximum would take 5-8 years, if cxBladder alone is their product.
2. CxColorectal will be ready for showtime in the next year or two.
3. They can fail because of external forces, like the highly politicised world of health in the USA.
4. They are a takeover opportunity when they start to eat into marketshare, until then, they are just a patent warehouse which a healthcare company could pick over the bones should PEB fail.
The risks are greater than you let on. If uptake is slow, then the share price will drop to 30c. They will likely be bought out by a health company who knows how to market products for a pittance
BUT, the rewards are huge should they deliver. Your share price will be more like $6 or $8 if they can manage the kind of earnings with multiple diagnostic products I think they are capable of.
Remember - it's not just CxBladder, but a whole suite of cancer diagnostic tests based on their patented technology.